International
Brasil 
Chile 
Deutschland 
España 
France 
Italia 
Panamá 
Portugal 
Russia 
UK 
Our results make us leaders but the real success lies in you becoming a mother
Our results make us leaders but the real success lies in you becoming a mother
We work to ensure you get pregnant in the shortest possible time. Here are the pregnancy rates for the IVI group in 2024.
At IVI, the chances of getting pregnant increase in each cycle. With your own eggs, in the first cycle, you have a 74% chance of getting pregnant (using all the embryos obtained in that cycle, but in different transfers), reaching 97% in the third cycle.
|
*Pregnancy rate after 3 cycles. Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
*Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
|
*Pregnancy rate after 3 cycles. Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
|
*Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
Age is a very important variable that affects treatment success rates. At IVI, these rates are so high because we personalise hormone stimulation, adapting it to the needs of each patient, and because we have advanced in-vitro fertilisation laboratories where the embryos are developed and selected under the best possible conditions.
 |
* * Cumulative pregnancy rate by age
Our egg donation patients become pregnant after an average of 2 cycles. If you are undergoing egg donation treatment, in the first cycle, you have an 83% chance of getting pregnant (using all the embryos obtained in that cycle, but in different transfers), reaching 99% on the third attempt.
|
* Pregnancy rate after 3 cycles. Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
* Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
|
* Pregnancy rate after 3 cycles. Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
|
* Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle. |
Preimplantation genetic testing allows us to detect alterations in the chromosomes (PGT-SR), in their number (PGT-A) or in a specific gene (PGT-M). Thanks to these tests, we can detect genetic problems in embryos and only transfer the optimal ones. This reduces the risk of miscarriage and increases the chances of having a healthy baby.
|
Pregnancy rate after 3 cycles. Each cycle includes the first fresh embryo transfer and subsequent transfers of all embryos generated and cryopreserved in that cycle.
|
At IVI, we offer safe and efficient treatments for both mothers and newborns.
Which is why we are committed to single embryo transfers, achieving high pregnancy rates and minimising multiple pregnancies to below 3%, thus reducing complications for both mother and baby.
At IVI, artificial insemination has a success rate of 51% using your partner’s semen over three cycles. If you use our sperm bank, your chances increase to 54.8%.
|
Cumulative pregnancy rates after three cycles of Artificial Insemination. |
Pregnancy rate: percentage of positive pregnancy biochemical test results in relation to the number of embryo transfers.
Deferred transfer: embryo transfer that does not occur in the ovarian stimulation cycle but in a later cycle with cryopreserved embryos.
Cumulative pregnancy rate of the cycle: percentage of positive pregnancy biochemical test results in relation to the number of embryo transfers. Including the transfer of cryopreserved embryos from the cycle.
NOTE: The data refers to procedures performed at our clinics in Spain, Lisbon, and Latin America (Chile, Panama, Salvador de Bahía).
Clinical results calculated based on data uploaded on 13/05/2025.
